Onderneming Infant Bacterial Therapeutics AB (publ) Other OTC
Aandelen
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-01-13 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 19-09-22 |
Chief Operating Officer | 57 | 20-10-14 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 04-12-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 24-09-15 |
Chairman | 74 | 01-01-11 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 04-05-17 |
Director/Board Member | 63 | 15-05-18 | |
Eva Idén
BRD | Director/Board Member | 58 | 04-05-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 10 | 453 283 | 0 | 0 | 87,87 % |
Aandeel B | 1 | 13 018 137 | 11 837 506 ( 90,93 %) | 0 |
Bedrijfsgegevens
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,88% | 80,5 mld. | |
+14,11% | 9,15 mld. | |
-14,14% | 4,9 mld. | |
+43,39% | 4,49 mld. | |
+18,90% | 4,44 mld. | |
+7,93% | 2,19 mld. | |
-28,40% | 2,13 mld. | |
+15,93% | 2,1 mld. | |
-43,17% | 1,78 mld. |